| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3cd12257804e2d7f96cff826faa97e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 |
| filingDate |
2004-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f21d1a7f3d472bb692e1a541d2ba7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3406eac39c46b539310e8ed034af885 |
| publicationDate |
2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-012033-B1 |
| titleOfInvention |
APPLICATION OF DEOXYPHEANINE FOR THE TREATMENT OF SCHIZOPHRENIC PSYCHOSES |
| abstract |
The use of deoxypeganine in the form of a free base or in the form of an acid addition salt or a deoxypeganine derivative, if the aforementioned derivative is simultaneously an inhibitor of acetylcholinesterase and monoamine oxidase for the manufacture of a medicament for the treatment of schizophrenic psychosis. |
| priorityDate |
2003-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |